CAL-101 (GS-1101)科研用抗肿瘤小分子靶向抑制剂-生物分子-试剂-生物在线
天津彬馨博澳科技发展有限公司
CAL-101 (GS-1101)科研用抗肿瘤小分子靶向抑制剂

CAL-101 (GS-1101)科研用抗肿瘤小分子靶向抑制剂

商家询价

产品名称: CAL-101 (GS-1101)科研用抗肿瘤小分子靶向抑制剂

英文名称: CAL-101 (GS-1101)

产品编号: S2226

产品价格: 0

产品产地: 美国

品牌商标: selleck

更新时间: null

使用范围: null

天津彬馨博澳科技发展有限公司
  • 联系人 :
  • 地址 : 天津市南开区卫津南路82号光明公寓
  • 邮编 :
  • 所在区域 : 天津
  • 电话 : 138****0000 点击查看
  • 传真 : 点击查看
  • 邮箱 : binxinbio@163.com

 

Biological Activity

DescriptionCAL-101 is a selective PI3K class I inhibitor of p110δ with IC50 of 2.5 nM.
Targetsp110δ
IC502.5 nM [1]
In vitroCAL-101 is not sensitive to other PI3K class I subunits including p110α, p110β, and p110γ. CAL-101 specifically blocks FcϵR1 p110δ-mediated CD63 expression with an EC50 of 8 nM in primary basophil. CAL-101 exhibits greater activity in B-cell acute lymphoblastic leukemia (B-ALL) and chronic lymphocytic leukemia (CLL) cells compared with acute myeloid leukemia (AML) and myeloproliferative neoplasm (MPN) cells. CAL-101 produces the reduction in pAktS473, pAktT308, and the downstream target S6 in SU-DHL-5, KARPAS-422 and CCRF-SB cells with EC50 of 0.1 to 1.0 μM. [1] CAL-101 induces selective cytotoxicity in CLL cells independent of IgVH mutational status or interphase cytogenetics, primarily through a caspase-dependent mechanism. CAL-101 induces cytotoxicity preferentially to CLL cells compared with normal B cells, without producing cytotoxicity in other hematopoietic cells, compared to LY294002. CAL-101 lacks direct cytotoxic potential to T cells and nature killer (NK) cells. CAL-101 can inhibit production of inflammatory cytokines, such as IL-6, IL-10, TNF-α, and IFN-γ, and activation-induced cytokines, such as CD40L. CAL-101 also antagonizes CD40L-mediated CLL cell survival. [2] CAL-101 induces an accumulation of cells in G1 and a decrease in the S-phase population in L1236 and L591 cells, which indicates CAL-101 as a novel strategy for the treatment of hodgkin lymphoma (HL). [3]
In vivo
Clinical TrialsCurrently under Phase II clinical trial in patients with relapsed or refractory hodgkin lymphoma.
Features

Protocol

Kinase Assay: [2]

PI3K assayPI3K assay is preformed on whole-cell lysates from CLL or normal B cells. A PI3K ELISA assay is performed. Briefly, whole-cell extracts are added to a mixture of PI(4,5)P2 substrate and reaction buffer containing adenosine triphosphate (ATP) and allowed to incubate at room temperature. The reaction is stopped by adding PI(3,4,5)P3 detector mixed with EDTA (ethylenediaminetetraacetic acid) and allowed to incubate at room temperature for 1 hour. After this time, the mixture is transferred from each well to a PI3K ELISA plate and allowed to incubate 1 hour. Plates are washed and then incubated with secondary detector for 30 minutes. Plates are washed again, and 3,3′,5,5′-tetramethylbenzidine solution is added for 5 minutes at which time H2SO4 is added to stop all reactions. Plates are read at 450 nm on a Labsystems 96-well plate reader.

Cell Assay: [2]

Cell LinesCLL B cells or healthy volunteer T cells or NK cells
Concentrations0.01-100 μM
Incubation Time48 hours
MethodsMTT assays are performed to determine cytotoxicity. 1 × 105 cells are incubated with CAL-101. MTT reagent is then added, and plates are incubated for an additional 20 hours before washing with protamine sulfate in phosphate-buffered saline. DMSO is added, and absorbance is measured by spectrophotometry at 540 nm in a Labsystems plate reader. Cell viability is also measured at various time points with the use of annexin/PI flow cytometry. Data are analyzed. At least 104 cells are counted for each sample. Results are expressed as the percentage of total positive cells over untreated control. Experiments examining caspase-dependent apoptosis included the addition of 100 μM Z-VAD. Experiments examining survival signals include the addition of 1 μg/mL CD40L, 800 U/mL IL-4, 50 ng/mL BAFF, 20 ng/mL TNF-α, or coculturing on fibronectin or stromal (HS-5 cell line) coated plates. Stromal coculture is done by plating a 75-cm2 flask (80%-100% confluent) per 6-well plate 24 hours before the addition of CLL cells.

References

Molecular Weight (MW)415.42
Formula

C22H18